Table 1 Clinicopathological characteristics
Total | MMR proficient | MMR deficient | p value | |
N = 76 (%) | N = 53 (%) | N = 23 (%) | ||
Age | ||||
<65 years | 42 (55) | 29 (55) | 13 (57) | 1.0000a |
≥65 years | 34 (45) | 24 (45) | 10 (44) | |
Race | ||||
White | 59 (78) | 40 (76) | 19 (83) | 0.7623a |
Black | 16 (21) | 12 (23) | 4 (17) | |
(Other) | 1 (1) | 1 (2) | 0 (0) | |
Parity | ||||
Nulliparous | 17 (22) | 10 (19) | 7 (30) | 0.3710a |
Multiparous | 58 (78) | 42 (81) | 16 (70) | |
(Unknown) | 1 (1) | 1 (1) | 0 (0) | |
Menstrual state | ||||
Pre-menopausal | 11 (15) | 9 (17) | 2 (9) | 0.7140a |
Post-menopausal | 65 (86) | 44 (83) | 21 (91) | |
Body mass index | ||||
<25 kg/m2 | 15 (20) | 11 (21) | 4 (17) | 0.7548a |
≥25 kg/m2 | 48 (63) | 31 (56) | 17 (74) | |
(Unknown) | 13 (17) | 11 (21) | 2 (9) | |
Smoking history | ||||
Never smoker | 58 (76) | 38 (72) | 20 (87) | 0.3610a |
Current or former smoker | 15 (20) | 12 (23) | 3 (13) | |
(Unknown) | 3 (4) | 3 (6) | 0 (0) | |
Histology | ||||
Endometrioid | 60 (79) | 38 (72) | 22 (96) | 0.0291a |
Non-endometrioid | 16 (21) | 15 (28) | 1 (4) | |
Histology grade | ||||
Low (G1, G2) | 48 (63) | 34 (64) | 14 (61) | 0.8008a |
High (G3) | 28 (37) | 19 (36) | 9 (39) | |
Myometrial invasion | ||||
Absent | 23 (30) | 17 (32) | 6 (26) | 0.7867a |
Present | 53 (70) | 36 (67) | 17 (74) | |
Lymphovascular space invasion | ||||
Absent or unknown | 60 (79) | 45 (85) | 15 (65) | 0.0692a |
Present | 16 (21) | 8 (15) | 8 (35) | |
FIGO 2009 stage | ||||
I | 54 (71) | 36 (68) | 18 (78) | 0.4967b |
II | 5 (7) | 5 (9) | 0 (0) | |
III | 11 (15) | 8 (15) | 3 (13) | |
IV | 6 (8) | 4 (8) | 2 (9) | |
Estrogen receptor | ||||
Negative | 1 (1) | 1 (2) | 0 (0) | 1.0000a |
Positive | 75 (99) | 52 (98) | 23 (100) | |
Progesterone receptor | ||||
Negative | 7 (9) | 5 (9) | 2 (9) | 1.0000a |
Positive | 69 (91) | 48 (90) | 21 (91) | |
ARID1A | ||||
Retain | 50 (66) | 42 (79) | 8 (35) | 0.0004a |
Loss | 26 (34) | 11 (21) | 15 (65) | |
Tumor PD-L1, case no. | ||||
Negative | 53 (70) | 42 (79) | 14 (61) | 0.1546a |
Positive | 23 (30) | 11 (21) | 9 (39) | |